← Back to graph
Prescription

colistimethate inhaled

Selected indexed studies

  • Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months. (Lancet Respir Med, 2024) [PMID:39270696]
  • Inhaled Colistimethate Sodium in the Management of Patients with Bronchiectasis Infected by Pseudomonas aeruginosa: A Narrative Review of Current Evidence. (Infect Drug Resist, 2022) [PMID:36540105]
  • Colistimethate. (, 2006) [PMID:30000388]

_Worker-drafted node — pending editorial review._

Connections

No connections recorded yet.

Sources

Local graph